Piper Sandler Upgrades Teva Pharma (TEVA) to Neutral
Tweet Send to a Friend
(Updated - January 3, 2024 4:24 AM EST)
Piper Sandler analyst David Amsellem upgraded Teva Pharma (NYSE: TEVA) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Piper Sandler analyst David Amsellem upgraded Teva Pharma (NYSE: TEVA) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
